ZHANG Kai 1,2 , SUN Xin 1,3 , YU Jiajie 1,3 , TANG Zhonglan 1,2 , FU Zengxiang 4 , XU Bin 1,2,5 , ZHU Xiangdong 1,2 , LIANG Jie 1,6 , LI Youping 1,3 , ZHANG Xingdong 1,2
  • 1. Research Base of Regulatory Science for Medical Device, National Medical Products Administration, Institute of Regulatory Science for Medical Device, Sichuan University, Chengdu, 610064, P.R.China;
  • 2. Engineering Research Center in Biomaterial, Sichuan University, Chengdu, 610064, P.R.China;
  • 3. China Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
  • 4. Life College of Northwest Polytechnic University, Xi'an, 710072, P.R.China;
  • 5. Sichuan Food and Drug Inspection and Testing Institute, Chengdu, 611731, P.R.China;
  • 6. Sichuan Medical Device Biomaterials and Products Inspection Center, Chengdu, 610064, P.R.China;
ZHANG Kai, Email: kaizhang@scu.edu.cn
Export PDF Favorites Scan Get Citation

Regulatory science of medical devices serves the scientific research and regulatory activities for supervision of medical devices. Principles of science and transparency and conduction of evidence-based study, which is advocated in Evidence-based science(EBS), also apply to regulatory science of medical devices, including using evidence-based scientific tools and methods to demonstrate the safety and effectiveness, as well as quality, efficacy and cost-effectiveness of total life cycle of medical products, target customers, and scope. EBS provides both new methods and tools for regulatory science for medical devices, and provides a new basis for further scientific regulatory decisions.

Citation: ZHANG Kai, SUN Xin, YU Jiajie, TANG Zhonglan, FU Zengxiang, XU Bin, ZHU Xiangdong, LIANG Jie, LI Youping, ZHANG Xingdong. Regulatory science for medical devices and evidence-based science. Chinese Journal of Evidence-Based Medicine, 2019, 19(5): 527-531. doi: 10.7507/1672-2531.201903142 Copy

  • Previous Article

    Using real-world evidence for drug and medical device evaluation and regulatory decisions
  • Next Article

    Risk factors for unplanned readmission in ischemic stroke patients within 31 days: a random forest algorithm research